Pengabad hägrar för Kaj: ”Aldrig sett något liknande”

En vinst för Sverige i Eurovision Song Contest på lördag skulle inte göra så stor skillnad för killarna i Kaj – deras kalender är redan fullbokad nästan ett år framåt. ”Jag har inte sett något liknande tidigare”, säger Markus Wiking på United Stage.

Sammanhang: ...En vinst för Sverige i Eurovision Song Contest på lördag skulle inte göra så stor skillnad för killarna i Kaj – deras kalender är redan fullbokad nästan ett år framåt. ”Jag har inte sett något liknande tidigare”, säger Markus Wiking på United Stage....

Omnämnda platser: Eurovision Song Contest, Kaj, Sverige. Omnämnda personer: Markus Wiking.

White & Case advises Adelis on partnering with Btwentyfour

Global law firm White & Case LLP has advised Adelis on its acquisition of a majority stake in Btwentyfour to support the company in its next stage of growth and product development. The transaction is expected to close in early 2025 subject to customary regulatory

Sammanhang: ...Global law firm White & Case LLP has advised Adelis on its acquisition of a majority stake in Btwentyfour to support the company in its next stage of growth and product development. The transaction is expected to close in early 2025 subject to customary regulatory approvals....

Omnämnda platser: Adelis. Omnämnda personer: with Btwentyfour Global.

Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses

Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the treatment of peritoneal carcinomatoses. The studies were closed

Sammanhang: ...Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the treatment of peritoneal carcinomatoses. ...

Omnämnda personer: Peritoneal Carcinomatoses Oncoinvent ASA.

Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients

Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian

Sammanhang: ...Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian cancer. ...

Omnämnda personer: with Radspherin.

Unlocking the Next Level: New Funding Programme Aims to Scale Fashion Innovation

13 March 2024: Global Fashion Agenda (GFA), a non-profit organisation accelerating the transition to a net positive fashion industry, has collaborated with PDS Ventures, the innovation and investment arm of PDS Limited, to launch a new Trailblazer Programme.

Sammanhang: ...The new initiative seeks to identify fashion’s most promising early-stage innovators and support them on their journey to scale....

Omnämnda platser: Funding Programme Aims.